Form 8-K - Current report:
SEC Accession No. 0001193125-20-229970
Filing Date
2020-08-25
Accepted
2020-08-25 16:31:00
Documents
18
Period of Report
2020-08-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d926663d8k.htm   iXBRL 8-K 38711
2 EX-1.1 d926663dex11.htm EX-1.1 53726
3 EX-4.1 d926663dex41.htm EX-4.1 17128
4 EX-5.1 d926663dex51.htm EX-5.1 10215
5 EX-5.2 d926663dex52.htm EX-5.2 8936
10 GRAPHIC g926663img07.jpg GRAPHIC 8590
  Complete submission text file 0001193125-20-229970.txt   344749

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA jnj-20200820.xsd EX-101.SCH 5122
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE jnj-20200820_def.xml EX-101.DEF 14774
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE jnj-20200820_lab.xml EX-101.LAB 24869
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jnj-20200820_pre.xml EX-101.PRE 15937
11 EXTRACTED XBRL INSTANCE DOCUMENT d926663d8k_htm.xml XML 9445
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0103
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 201132626
SIC: 2834 Pharmaceutical Preparations